We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TWST market cap is 2.8B. The company's latest EPS is USD -3.5165 and P/E is -13.05.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 66.95M | 71.5M | 75.3M | 81.46M | 84.71M |
| Operating Income | -53.73M | -46.98M | -48.89M | -88.92M | -36.04M |
| Net Income | -46.24M | -43.01M | -45.49M | -85.57M | -34.66M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 90.1M | 132.87M | 217.81M | 251.02M | 312.97M |
| Operating Income | -139.88M | -152.73M | -234.78M | -217.16M | -220.83M |
| Net Income | -139.73M | -152.1M | -217.86M | -204.62M | -208.73M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 776.4M | 732.82M | 702.85M | 638.12M | 614.32M |
| Total Liabilities | 152.97M | 142.77M | 142.72M | 146.98M | 141.63M |
| Total Equity | 623.43M | 590.04M | 560.13M | 491.14M | 472.69M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 398.88M | 702.1M | 961.38M | 776.4M | 614.32M |
| Total Liabilities | 62.62M | 121.28M | 171.99M | 152.97M | 141.63M |
| Total Equity | 336.26M | 580.82M | 789.39M | 623.43M | 472.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -142.47M | -22.97M | -42.4M | -48.77M | -64.09M |
| Investing | 50.61M | 4.17M | -1.08M | -1.79M | -3.07M |
| Financing | 911k | -1.47M | 355k | 3.26M | 6.89M |
| Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -142.26M | -112.24M | -124.39M | -142.47M | -64.09M |
| Investing | -114.65M | 156.16M | -232.93M | 50.61M | -3.07M |
| Financing | 303.73M | 329.18M | 270.53M | 911k | 6.89M |
| Market Cap | 2.8B |
| Price to Earnings Ratio | -13.05 |
| Price to Sales Ratio | 8.71 |
| Price to Cash Ratio | 12.04 |
| Price to Book Ratio | 5.76 |
| Dividend Yield | - |
| Shares Outstanding | 59.36M |
| Average Volume (1 week) | 738.53k |
| Average Volume (1 Month) | 739.15k |
| 52 Week Change | 33.67% |
| 52 Week High | 60.90 |
| 52 Week Low | 27.41 |
| Spread (Intraday) | 7.29 (15.19%) |
| Company Name | Twist Bioscience Corporation |
| Address |
3500 south dupont highway dover, delaware 19901 |
| Website | https://www.twistbioscience.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
